Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Celldex Therapeutics buy Citigroup Inc.

Celldex Therapeutics
Start price
€28.20
07.10.24 / 50%
Target price
€63.74
07.10.25
Performance (%)
-20.57%
End price
€22.40
08.10.25
Summary
This prediction ended on 08.10.25 with a price of €22.40. The prediction for Celldex Therapeutics disappointed with a performance of -20.57%. Citigroup_Inc_ has a follow-up prediction for Celldex Therapeutics where he still thinks Celldex Therapeutics is a Buy. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Celldex Therapeutics 6.422% 6.422% -1.695%
iShares Core DAX® 1.644% 4.865% 25.089%
iShares Nasdaq 100 0.747% 2.923% 8.975%
iShares Nikkei 225® 2.442% 6.212% 21.408%
iShares S&P 500 0.618% 2.843% 5.726%

Comments by Citigroup_Inc_ for this prediction

In the thread Celldex Therapeutics diskutieren
Prediction Buy
Perf. (%) -20.57%
Target price 63.742
Change
Ends at 07.10.25

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $70.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat

Citigroup Inc. 
0
Report Share
07.10.24
In the thread Trading Celldex Therapeutics
Prediction Buy
Perf. (%) -20.57%
Target price 63.742
Change
Ends at 07.10.25

Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten

Citigroup Inc. 
0
Report Share
08.10.25

Current prediction by Citigroup_Inc_ for Celldex Therapeutics

buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€18.40
20.08.25
€41.27
20.08.26
21.74%
12.01.26

Citigroup Inc. 
20.08.25 50%